Reply To: Cautious Investor — Market Weekly

#98635
Truman
Participant

After-Hours:

Amylyx Pharmaceuticals (AMLX) to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026.
AMLX +14.3%

Andersen (ANDG) launches secondary offering of 4.28M Class A shares.
ANDG -4.5%

Coherent (COHR) begins customer sampling of 300mm silicon carbide substrates for AI infrastructure
COHR +0.4%

Firefly Aerospace (FLY) onboarded to NASA spacecraft processing contract at Vandenberg.
FLY +0.1%